Clinical Trial Update: A Study of Immunotherapy With TIL (Tumor Infiltrating Lymphocytes) in Combination With Intra-tumoral Injections of Interferon Gamma-adenovirus (Ad-IFNg) in Patients With Stage IIIc or Stage IV Metastatic Melanoma (AJCC)(Protocol TIL-Ad-INFg) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study evaluating tumor-infiltrating lymphocytes combined with intra-tumoral injections of Ad-IFNg (interferon gamma-encoding adenovirus) in stage II…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Ad-IFNg (interferon gamma-encoding adenovirus)
• TIL therapy (tumor-infiltrating lymphocytes) (tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Nantes University Hospital | Conditions: Metastatic Melanoma | Phase 1, Phase 2 | Status: TERMINATED